AlbiVax

N/A

Report date: 2025/03/17 20:00:36

Base Information

Drug NameAlbiVax
Drug Alias Namealbumin/vaccine nanocomplexes (NIH)lymph‐node‐targeted nanovaccines (NIH)
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionSerum albumin modulators
TargetsSerum albumin
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institutes Of Health
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of Health
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A